Patents by Inventor Max LATAILLADE

Max LATAILLADE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV MATURATION INHIBITOR FORMULATIONS
    Publication number: 20200268772
    Abstract: Co-formulations of HIV maturation inhibitor compound with one or two other HIV compounds, and methods of treatment, are set forth.
    Type: Application
    Filed: November 18, 2016
    Publication date: August 27, 2020
    Inventors: Albert J. DELMONTE, Ira B. DICKER, Carey Kang-Lun HWANG, Samit Ramesh JOSHI, Max LATAILLADE
  • FOSTEMSAVIR FOR USE IN HEAVILY TREATMENT-EXPERIENCED HIV-1 INFECTED INDIVIDUALS
    Publication number: 20190030025
    Abstract: A method of attaining virologic suppression in a heavily treatment-experienced (HTE) individual infected with the HIV-1 virus involves administering to the individual a treatment regimen comprising the drug fostemsavir together with an optimized background therapy (OBT). This treatment regimen should maintain virologic suppression to a plasma HIV-1 RNA level of less than 200 copies (c)/mL for an extended period.
    Type: Application
    Filed: February 2, 2017
    Publication date: January 31, 2019
    Inventors: Dennis Michael GRASELA, George HANNA, Mark R. KRYSTAL, Max LATAILLADE